Dietary selenium (Se) and Vitamin E (VE) supplementation modulated methylmercury-mediated changes in markers of cardiovascular diseases in rats

Cardiovascular Toxicology

Volumn 12, Issue 1, 2012, Pages 10-24

  Jin, Xiaolei ^a   Hidiroglou, Nick ^b   Lok, Eric ^a   Taylor, Marnie ^a   Kapal, Kamla ^a   Ross, Nikia ^a   Sarafin, Kurtis ^b   Lau, Andrea ^a   De Souza, Andrea ^a   Chan, Hing Man ^c   Mehta, Rekha ^a  

^a TOXICOLOGY RESEARCH DIVISION   (Canada)

^b HEALTH CANADA   (Canada)

^c UNIVERSITY OF NORTHERN BRITISH COLUMBIA   (Canada)

Author keywords

8 Hydroxydeoxyguanosine; C reactive protein; Cardiovascular disease; Intercellular adhesion molecule 1; Isoprostane; Methylmercury; Monocyte chemotactic protein 1; Oxidative stress; Oxidized LDL; Paraoxonase; Protein carbonyl; Selenium; Total antioxidant capacity; Vitamin E

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALPHA TOCOPHEROL; ARYLDIALKYLPHOSPHATASE 1; C REACTIVE PROTEIN; CARBONYL DERIVATIVE; INTERCELLULAR ADHESION MOLECULE 1; ISOPROSTANE DERIVATIVE; METHYLMERCURY; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; SELENIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIET THERAPY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; ENZYME ACTIVITY; FEEDING; INFLAMMATION; LEUKOCYTE COUNT; MALE; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; TREATMENT RESPONSE; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; MALE; METHYLMERCURY COMPOUNDS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SELENIUM; VITAMIN E;

ANIMALIA; RATTUS;

EID: 84858799745     PISSN: 15307905     EISSN: 15590259     Source Type: Journal    
DOI: 10.1007/s12012-011-9134-y     Document Type: Article

References (69)

1. Chan, H. M., Kim, C., Khoday, K., Receveur, O., & Kuhnlein, H. V. (1995). Assessment of dietary exposure to trace metals in Baffin Inuit food. Environmental Health Perspective, 103(7-8), 740-746.
2. Chan, H. M. (1998). A database for environmental contaminants in traditional foods in northern and arctic Canada: Developmental and applications. Food Additives and Contaminants, 15(2), 127-134.
3. Belanger, M., Dewailly, E., Berthiaume, L., Noël, M., Bergeron, J., Mirault, M., et al. (2006). Dietary contaminants and oxidative stress in Inuit of Nunavik. Metabolism, 55(8), 989-995.
4. Salonen, J. T., Seppänen, K., Nyyssönen, K., Korpela, H., Kauhanen, J., Kantola, M., et al. (1995). Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation, 91(3), 645-655.
5. Fillion, M., Mergler, D., Sousa Passos, C. J., Larribe, F., Lemire, M., & Guimarães, J. R. (2006). A preliminary study of mercury exposure and blood pressure in the Brazilian Amazon. Environmental Health, 5, 29.
6. Valera, B., Dewailly, E., & Poirier, P. (2008). Cardiac autonomic activity and blood pressure among Nunavik Inuit adults exposed to environmental mercury: A cross-sectional study. Environmental Health, 7, 29.
7. Valera, B., Dewailly, E., & Poirier, P. (2009). Environmental mercury exposure and blood pressure among Nunavik Inuit adults. Hypertension, 54(5), 981-986.
8. Choi, A. L., Weihe, P., Budtz-Jørgensen, E., Jørgensen, P. J., Salonen, J. T., Tuomainen, T. P., et al. (2009). Methylmercury exposure and adverse cardiovascular effects in Faroese whaling men. Environmental Health Perspective, 117(3), 367-372.
9. Chapman, L., & Chan, H. M. (2000). The influence of nutrition on methyl mercury intoxication. Environmental Health Perspective, 108(supp1), 29-56. (Pubitemid 30168694)
10. Ralston, N. V., Blackwell, J. L., III, & Raymond, L. J. (2007). Importance of molar ratios in selenium-dependent protection against methylmercury toxicity. Biological Trace Element Research, 119(3), 255-268. (Pubitemid 350085249)
11. Welsh, S. O. (1979). The protective effect of vitamin E and N, N′-diphenyl-p-phenylenediamine (DPPD) against methyl mercury toxicity in the rat. Journal of Nutrition, 109(10), 1673-1681.
12. Hirota, Y. (1978). Effect of selenium and vitamin E on the subacute toxicity of methylmercury in the adult cat (author's transl). Nippon Eiseigaku Zasshi, 33(4), 589-605.
13. Sarafian, T. A. (1999). Methylmercury-induced generation of free radicals: Biological implication. Metal Ions in Biological Systems, 36, 415-444.
14. Zalups, R. K. (2000). Molecular interactions with mercury in the kidney. Pharmacological Reviews, 52(1), 113-143.
15. Jin, X., Chan, H. M., Lok, E., Kapal, K., Taylor, M., Kubow, S., et al. (2008). Dietary fats modulate methylmercury-mediated systemic oxidative stress and oxidative DNA damage in rats. Food Chemical Toxicology, 46, 1706-1720.
16. Devaraj, S., Singh, U., & Jialal, I. (2009). The evolving role of C-reactive protein in atherothrombosis. Clinical Chemistry, 55(2), 229-238.
17. Cersosimo, E., & DeFronzo, R. A. (2006). Insulin resistance and endothelial dysfunction: The road map to cardiovascular diseases. Diabetes/Metabolism Research and Reviews, 22(6), 423-436. (Pubitemid 44774046)
18. Kishimoto, T., Oguri, T., & Tada, M. (1995). Effects of methylmercury (Ch3HgCl) injury on nitric oxide synthase (NOS) activity in cultured human umbilical vascular endothelial cells. Toxicology, 103, 1-7. (Pubitemid 3007079)
19. Ohno, M., Kishimoto, T., & Tada, M. (1995). The effect of methylmercury (Ch3HgCl) on the production of endothelium-derived relaxing factor (EDRF) by cultured human umbilical vascular endothelial cells based on its anti-aggregatory effect on human platelets. Cell Biology and Toxicology, 11, 303-311. (Pubitemid 3012079)
20. Hagele, T. J., Mazerik, J. N., Gregory, A., Kaufman, B., Magalang, U., Kuppusamy, M. L., et al. (2007). Mercury activates vascular endothelial cell phospholipase D through thiols and oxidative stress. International Journal of Toxicology, 26, 57-69. (Pubitemid 46360918)
21. Mazerik, J. N., Hagele, T., Sherwani, S., Ciapala, V., Butlter, S., Kuppusamy, M., et al. (2007). Phospholipase A2 activation regulates cytotoxicity of methylmercury in vascular endothelial cells. International Journal of Toxicology, 26, 553-569. (Pubitemid 350232915)
22. Ingold, K. U., Burton, G. W., Foster, D. O., Hughes, L., Lindsay, D. A., & Webb, A. (1987). Biokinetics of and discrimination between dietary RRR and SRR-alpha tocopherols in the male rat. Lipids, 22, 163-172. (Pubitemid 17044186)
23. Thompson, J. N., & Hatina, G. (1979). Determination of tocopherols and tocotrienols in foods amd tissues by high pressure liquid chromatography. Journal of Liquid Chromatography, 2, 327-344. (Pubitemid 9157107)
24. Praticò, D. (2008). Prostanoid and isoprostanoid pathways in atherogenesis. Atherosclerosis, 201, 8-16.
25. Basu, S. (2008). F2-isoprostanes in human health and diseases from molecular mechanisms to clinical implication. Antioxidants & Redox Signaling, 10(8), 1405-1434.
26. Robers, I. J., I. I., Oates, J. A., Linton, M. F., Fazio, S., Meador, B. P., Gross, M. D., et al. (2007). The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radical Biology and Medicine, 43, 1388-1393.
27. Stringari, J., Nunes, A. K., Franco, J. L., Bohrer, D., Garcia, S. C., Dafre, A. L., et al. (2008). Prenatal methylmercury exposure hampers glutathione antioxidant system ontogenesis and causes long-lasting oxidative stress in the mouse brain. Toxicology Applied Pharmacology, 227(1), 147-154. (Pubitemid 351179850)
28. Yin, Z., Milatovic, D., Aschner, J. L., Syversen, T., Rocha, J. B., Souza, D. O., et al. (2007). Methylmercury induces oxidative injury, alterations in permeability and glutamine transport in cultured astrocytes. Brain Research, 1131(1), 1-10. (Pubitemid 46053894)
29. Vendrell, I., Carrascal, M., Vilaro, M., Abian, J., Rodriguez- Farre, E., & Sunol, C. (2007). Cell viability and proteomic analysis in cultured neurons exposed to methylmercury. Human Experimental Toxicology, 26, 263-272. (Pubitemid 46733349)
30. Ando, T., Wakisaka, I., Yanagihashi, T., & Sakamoto, M. (1989). Lipid peroxidation induced by methylmercury in rats. Nippon Eiseigaku Zasshi, 44(3), 733-738. (Pubitemid 19242362)
31. Ando, T., Yanagihashi, T., Wakisaka, I., & Sakamoto, M. (1989). Induction of lipid peroxidation and change of fatty acid composition in rats fed methylmercury. Nippon Eiseigaku Zasshi, 44(5), 993-1001. (Pubitemid 20278290)
32. Suzuki, T., Harashima, H., & Kamiya, H. (2010). Effects of base excision repair protein on mutagenesis by 8-oxo-7, 8-dihydroguanine (8-hydroxyguanine) pared with cysteine and adenine. DNA Repair (Amst), 9(5), 542-550.
33. Dalle-Donne, I., Aldini, G., Carini, M., Colombo, R., Rossi, R., & Milzani, A. (2006). Protein carbonylation cellular dysfunction, and disease progression. Journal of Cellular and Molecular Medicine, 10(2), 389-406. (Pubitemid 44870187)
34. Dalle-Donne, I., Giustarini, D., Colombo, R., Rossi, R., & Milzani, A. (2003). Protein carbonylation in human diseases. TRENDS in Molecular Medicine, 9(4), 169-176. (Pubitemid 36626706)
35. Wong, C. M., Marcocci, L., Liu, L., & Suzuki, Y. J. (2010). Cell signaling by protein carbonylation and decarbonylation. Antioxidant and Redox Signaling, 12(3), 393-404.
36. Wong, C. M., Cheema, A. K., Zhang, L., & Suzuki, Y. J. (2008). Protein carbonylation as a novel mechanism in redox signalling. Circulation Research, 102, 310-318. (Pubitemid 351271651)
37. Murotomi, K., Takagi, N., Takeo, S., & Tanonaka, K. (2011). NADPH oxidase-mediated oxidative damage to proteins in the postsynaptic density after transient cerebral ischemia and reperfusion. Molecular and Cellular Neuroscience, 46, 681-688.
38. Nyström, T. (2005). Role of oxidative carbonylation in protein quality control and senescence. The EMBO Journal, 24, 1311-1317.
39. Aldini, G., Dalle-Donne, I., Facino, R. M., Milzani, A., & Carini, M. (2007). Intervention strategies to inhibit protein carbonylation by lipooxidation-derived reactive carbonyls. Medicinal Research Reviews, 27(6), 817-868. (Pubitemid 350035121)
40. Lim, P. S., Wu, M. Y., Chien, S. W., Wu, T. K., Liu, C. S., Hu, C. Y., et al. (2008). Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease. Nephrology (Carlton), 13(8), 677-683.
41. Venardos, K., Harrison, G., Headrick, J., & Perkins, A. (2004). Selenium supplementation and ischemia-reperfusion injury in rats. Redox Report, 9(6), 317-320. (Pubitemid 40185435)
42. Raines, A. M., & Sunde, R. A. (2011). Selenium toxicity but not deficient or super-nutritional selenium status vastly alters the transcriptome in rodents. Raines and Sunde BMC Genomics, 12, 26.
43. Labunskyy, V. M., Lee, B. C., Handy, D. E., Loscalzo, J., Hatfield, D. L., & Gladyshev, V. N. (2011). Both maximal expression of selenoproteins and selenoprotein deficiency can promote development of type 2 diabetes-like phenotype in mice. Antioxid Redox Signal, 14(12), 2327-2336.
44. Yamashita, T., Ando, Y., Nakamura, M., Obayashi, K., Terazaki, H., Haraoka, K., et al. (2004). Inhibitory effect of α-tocopherol on methylmercury-induced oxidative stress. Environmental Health and Preventive Medicine, 9(3), 111-117. (Pubitemid 38856192)
45. Ishigaki, Y., Oka, Y., & Katagiri, H. (2009). Circulating oxidized LDL: A biomarker and a pathogenic factor. Current Opinion in Lipidology, 20, 363-369.
46. Lippi, G., Favaloro, E. J., Montagnana, M., & Franchini, M. (2010). C-reactive protein and venous thromboembolism: Causal or casual association? Clinical Chemical Laboratory Medicine, 48(12), 1693-1701.
47. Calabro, P., Golia, E., & Yeh, E. T. H. (2009). CRP and the risk of atherosclerotic events. Seminars in Immunopathology, 31, 79-94.
48. Marnell, L., Mold, C., & Clos, T. W. D. (2005). C-reactive protein: Ligands, receptors and role in inflammation. Clinical immunology, 117, 104-111. (Pubitemid 41407719)
49. Devaraj, S., Singh, U., & Jialal, I. (2009). The evolving role of the c-reactive protein in atherothrombosis. Clinical Chemistry, 55(2), 229-238.
50. Reeves, M. A., & Hoffmann, P. R. (2009). The human selenoproteome: Recent insights into functions and regulation. Cellular and Molecular Life Sciences, 66, 2457-2478.
51. Navarro-Alarcon, M., & Cabrera-Vique, C. (2008). Selenium in food and the human body: A review. Science of Total Environment, 400(1-3), 115-141.
52. Khan, M. A. K., & Wang, F. (2009). Mercury-selenium compounds and their toxicological significance: Toward a molecular understanding of the mercury-selenium antagonism. Environmental Toxicology and Chemistry, 28(8), 1567-1577.
53. Rigotti, A. (2007). Absorption, transport, and tissue delivery of vitamin E. Molecular Aspects of Medicine, 28, 423-436.
54. Azzi, A. (2007). Molecular mechanism of a-tocopherol action. Free Radical Biology and Medicine, 43, 16-21.
55. Munteanu, A., & Zingg, J.-M. (2007). Cellular, molecular, and clinical aspects of vitamin E on atherosclerosis prevention. Molecular Aspects of Medicine, 28, 538-590. (Pubitemid 47628863)
56. Traber, M. G. (2010). Regulation of xenobiotic metabolism, the only signalling function of alpha tocopherol? Molecular Nutrition & Food Research, 54, 1-8.
57. Su, M. Q., & Okita, G. T. (1986). Effects of methylmercury on hypnotic action of hexobarbital, liver hydroxylase and cytochrome P-450 in mice. Toxicology, 39(3), 233-245.
58. Lucier, G. W., Matthews, H. B., Brubaker, P. E., Klein, R., & McDaniel, O. S. (1973). Effects of methylmercury on microsomal mixed-function oxidase components of rodents. Molecular Pharmacology, 9(2), 237-246.
59. Saremi, A., & Arora, R. (2010). Vitamin E and cardiovascular disease. American Journal of Therapeutics, 17(3), e56-e65.
60. Dotan, Y., Pinchuk, I., Lichtenberg, D., & Leshno, M. (2009). Decision analysis supports the paradigm that indiscriminate supplementation of vitamin E does more harm than good. Arteriosclerosis, Thrombosis, and Vascular Biology, 29, 1304-1309.
61. Falcone, E. L., Mangili, A., Tang, A. M., Jones, C. Y., Woods, M. N., Polak, J. F., et al. (2010). Micronutrient concentrations and subclinical atherosclerosis in adults with HIV. American Journal of Clinical Nutrition, 91(5), 1213-1219.
62. Goswami, B., Tayal, D., Gupta, N., & Mallika, V. (2009). Paraoxonase: A multifaceted biomolecule. Clinica Chimica Acta, 410(1-2), 1-12.
63. Shih, D. M., & Lusis, A. J. (2009). The roles of PON1 and PON2 in cardiovascular disease and innate immunity. Current Opinion in Lipidology, 20(4), 288-292.
64. Soran, H., Younis, N. N., Charlton-Menys, V., & Durrington, P. (2009). Variation in paraoxonase-1 activity and atherosclerosis. Current Opinion in Lipidology, 20(4), 265-274.
65. Dewailly, E. C., Muckle, G., & Ayotte, P. (2009). Contaminant exposure and emergence of cardiovascular diseases in Inuit. In S. Smith, J. Stow, & J. Edwards (Eds.), Synopsis of research conducted under the 2008-2009 Northern contaminant program (pp. 24-41). Ottawa: Indian and Northern Affairs Canada.
66. Gonzalvo, M. C., Gil, F., Hernández, A. F., Villanueva, E., & Pla, A. (1997). Inhibition of paraoxonase activity in human liver microsomes by exposure to EDTA, metals and mercurials. Chemico-Biological Interactions, 105(3), 169-179. (Pubitemid 27353307)
67. Costa, L. G., Vitalone, A., Cole, T. B., & Furlong, C. E. (2005). Modulation of paraoxonase (PON1) activity. Biochemical Pharmacology, 69(4), 541-550.
68. Pla, A., Rodrigo, L., Hernández, A. F., Gil, F., & Lopez, O. (2007). Effect of metal ions and calcium on purified PON1 and PON3 from rat liver. Chemico-Biological Interactions, 167(1), 63-70. (Pubitemid 46413237)
69. Gençer, N., & Arslan, O. (2009). Purification human PON1Q192 and PON1R192 isoenzymes by hydrophobic interaction chromatography and investigation of the inhibition by metals. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences, 877(3), 134-140.